China SXT Pharmaceuticals
SXTC
SXTC
7 hedge funds and large institutions have $79.9K invested in China SXT Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and closing their positions.
Holders
7
Holders Change
+3
Holders Change %
+75%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $34K | 31,607 | +31,607 | New |
|
2
Citadel Advisors
Miami,
Florida
| $17.4K | 16,115 | +16,115 | New |
|
3
UBS Group
Zurich,
Switzerland
| $13.7K | 12,575 | +12,567 | +157,088% |
|
4
Bank of Montreal
Toronto,
Ontario, Canada
| $12.5K | 10,000 | +10,000 | New |
|
5
Acadian Asset Management
Boston,
Massachusetts
| $2K | 2,759 | – | – |
|
6
Qube Research & Technologies (QRT)
London,
United Kingdom
| $327 | 303 | +200 | +194% |
|
|
BCV
7
Banque Cantonale Vaudoise
Lausanne,
Switzerland
| $0 | 1 | – | – |
|
|
CFGS
8
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|